Sandercock Brett 4

What Happened
Brett Sandercock, CFO of ResMed Inc. (RMD), disposed of 1,000 shares on 2026-03-02 at $254.30 per share, generating $254,300 in proceeds. The transaction is reported as a sale (disposition), which for executives is commonly routine rather than a direct signal of company outlook.

Key Details

• Transaction date: 2026-03-02; reported on Form 4 filed 2026-03-03.
• Price and amount: 1,000 shares at $254.30 each; total value $254,300.
• Transaction type: Sale (code S) — reported as open-market or private sale.
• Shares owned after transaction: Not specified in the information provided in this summary.
• Footnote: Transaction was executed under a Rule 10b5-1 trading plan adopted February 19, 2025 (pre-arranged plan).
• Timeliness: Filing covers the transaction the prior day; no late filing indicated in the report.

Context
A 10b5-1 plan allows insiders to sell or buy shares according to a pre-set schedule and is often used to avoid questions about timing or intent. Such planned sales are generally considered routine reporting of liquidity rather than an explicit endorsement or negative signal about company prospects.